FUJIFILM Diosynth Biotechnologies, a world-leading contract development and manufacturing organization (CDMO) for biologics, vaccines, advanced therapies and oncolytic viruses enters a non-exclusive strategic partnership agreement with SHL Medical (SHL), a world-leading solutions provider of advanced drug delivery systems.

SHL’s continuous improvement efforts have been recognized with a total of three awards from Taiwan’s two prestigious competitions – Excellent Practice Award (EPA) from the Association of Quality Manager and Taiwan Continuous Improvement Awards (TCIA) from Corporate Synergy Development Center.